Sanara MedTechSMTI +2.48%72 Days Inventory is 167.66 as of Mar. 2026, which is 11% below its 10-year median of 187.46. GuruFocus rates SMTI with a GF Score™ of 72/100 and a GF Value™ of $45.63 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Sanara MedTech ranks better than 56.36% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Sanara MedTech's Average Total Inventories for the
three
months ended in Mar. 2026 was $3.5 Mil. Sanara MedTech's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $1.9 Mil.
Hence, Sanara MedTech's Days Inventory for the
three
months ended in Mar. 2026 was 167.66.
The historical rank and industry rank for Sanara MedTech's Days Inventory or its related term are showing as below:
SMTI'
s Days Inventory Range Over the Past 10 Years
Min: 146.54 Med: 187.46 Max: 422.48
Current: 164.29
During the past 13 years, Sanara MedTech's highest Days Inventory was 422.48. The lowest was 146.54. And the median was 187.46.
SMTI's Days Inventory is ranked better than 56.36% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs SMTI: 164.29
Sanara MedTech's Days Inventory
increased
from Mar. 2025 (146.99) to Mar. 2026 (167.66).
It might indicate that Sanara MedTech's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sanara MedTech's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sanara MedTech's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.13.
Sanara MedTech (NAS:SMTI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sanara MedTech's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sanara MedTech's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sanara MedTech Days Inventory Related Terms
Sanara MedTech Days Inventory Historical Data
* Premium members only.
The historical data trend for Sanara MedTech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMTI vs EMBC, KRMD, UTMD: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Sanara MedTech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanara MedTech Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sanara MedTech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanara MedTech (SMTI) has a Days Inventory of 167.66 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sanara MedTech and its competitors. This is 11% below median its historical median of 187.46. Over the past decade, Sanara MedTech's Days Inventory has ranged from 146.54 to 422.48. According to the industry distribution chart, Sanara MedTech ranks #343 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 43.6%.
Is Sanara MedTech's Days Inventory too high?
Sanara MedTech's current Days Inventory of 167.66 is 11% below median its 10-year median of 187.46. Over the past 10 years, this metric has ranged from a low of 146.54 to a high of 422.48. The Medical Devices & Instruments industry median Days Inventory is 179.60. Sanara MedTech's value of 167.66 is 6.6% below this industry median. Based on the distribution chart, Sanara MedTech ranks #343 out of 786 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sanara MedTech has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanara MedTech's Days Inventory compare to EMBC and KRMD?
According to the Medical Devices & Instruments industry distribution chart, Sanara MedTech ranks #343 out of 786 companies for Days Inventory. This puts Sanara MedTech in the upper half of its industry. The industry median Days Inventory is 179.60. Sanara MedTech's value of 167.66 is 6.6% below this benchmark. Historically, Sanara MedTech's own Days Inventory has ranged from 146.54 to 422.48 over the past decade. While the company's 10-year median is 187.46 vs. the industry median of 179.60, Sanara MedTech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanara MedTech's current Days Inventory of 167.66 is 6.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sanara MedTech and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanara MedTech's current Days Inventory is 167.66, which is 11% below median its own 10-year median of 187.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanara MedTech stock overvalued right now?
Based on GuruFocus' analysis, Sanara MedTech (SMTI) is currently considered Possible Value Trap. The stock's GF Value™ is $45.63, compared to a current price of $24.85 — trading 45.5% below its estimated fair value. The current Days Inventory is 167.66, which is 11% below median its 10-year median of 187.46 and 6.6% below the Medical Devices & Instruments industry median of 179.60. Sanara MedTech's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sanara MedTech (SMTI), the current Days Inventory is 167.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanara MedTech (SMTI) Overvalued in 2026?
Based on GuruFocus' analysis, Sanara MedTech stock appears to be undervalued.
The current stock price of $24.85 is trading 45.5% below its estimated GF Value™ of $45.63.
GuruFocus considers Sanara MedTech to be Possible Value Trap.
Key valuation signals for SMTI:
Days Inventory: 167.66 (11% below median its 10-year median of 187.46)
GF Value™: $45.63 vs. price of $24.85 (45.5% below fair value)
Industry Position: 6.6% below the Medical Devices & Instruments median (#343 of 786)
No single metric tells the full story. See the SMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
72GF Score
Get the complete analysis for SMTI
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SMTI has been successfully added to your 
